Botulinum A toxin as a treatment for overactive rectum with associated faecal incontinence

Colorectal Disease

Volumn 14, Issue 3, 2012, Pages 342-348

  Bridoux, V ^a   Gourcerol, G ^a   Kianifard, B ^a   Touchais, J Y ^a   Ducrotte, P ^a   Leroi, A M ^a   Michot, F ^a   Tuech, J J ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Botox; Botulinum toxin; Faecal incontinence; Overactive rectum

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; FECAL INCONTINENCE QUALITY OF LIFE; FECES INCONTINENCE; FEMALE; HUMAN; INTESTINAL DYSMOTILITY; INTESTINE CONTRACTION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OVERACTIVE RECTUM; PERISTALSIS; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; FECAL INCONTINENCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MANOMETRY; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECTUM; SIGMOIDOSCOPY; TREATMENT OUTCOME;

EID: 84856764237     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02585.x     Document Type: Article

References (29)

1. Perry S, Shaw C, McGrother C et al. ; Leicestershire MRC Incontinence Study Team. Prevalence of faecal incontinence in adults aged 40years or more living in the community. Gut 2002; 50: 480-4.
2. Whitehead WE, Borrud L, Goode PS et al. ; Pelvic Floor Disorders Network. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 2009; 137: 512-7.
3. Engel AF, Kamm MA, Bartram CI, Nicholls RJ. Relationship of symptoms in faecal incontinence to specific sphincter abnormalities. Int J Colorectal Dis 1995; 10: 152-5.
4. Vaizey CJ, Kamm MA, Bartram CI. Primary degeneration of the internal anal sphincter as a cause of passive faecal incontinence. Lancet 1997; 349: 612-5.
5. Gee AS, Durdey P. Urge incontinence of faeces is a marker of severe external anal sphincter dysfunction. Br J Surg 1995; 82: 1179-82.
6. Herbst F, Kamm MA, Morris GP, Britton K, Woloszko J, Nicholls RJ. Gastrointestinal transit and prolonged ambulatory colonic motility in health and faecal incontinence. Gut 1997; 41: 381-9.
7. Santoro GA, Eitan BZ, Pryde A, Bartolo DC. Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum 2000; 43: 1676-81.discussion 1681-2.
8. Chan CL, Lunniss PJ, Wang D, Williams NS, Scott SM. Rectal sensorimotor dysfunction in patients with urge faecal incontinence: evidence from prolonged manometric studies. Gut 2005; 54: 1263-72.
9. Bakx R, Doeksen A, Slors JF, Bemelman WA, van Lanschot JJ, Boeckxstaens GE. Neorectal irritability after short-term preoperative radiotherapy and surgical resection for rectal cancer. Am J Gastroenterol 2009; 104: 133-41.
10. Kenefick NJ, Vaizey CJ, Cohen RC, Nicholls RJ, Kamm MA. Medium-term results of permanent sacral nerve stimulation for faecal incontinence. Br J Surg 2002; 89: 896-901.
11. Lefèvre JH, Parc Y, Giraudo G, Bell S, Parc R, Tiret E. Outcome of antegrade continence enema procedures for faecal incontinence in adults. Br J Surg 2006; 93: 1265-9.
12. Williams NS, Ogunbiyi OA, Scott SM, Fajobi O, Lunniss PJ. Rectal augmentation and stimulated gracilis anal neosphincter: a new approach in the management of fecal urgency and incontinence. Dis Colon Rectum 2001; 44: 192-8.
13. Lehur PA, Leroi AM. Anal incontinence in adults. Guidelines for clinical practice. National French Gastroenterology Society. Gastroenterol Clin Biol 2000; 24: 299-314.
14. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993; 36: 77-97.
15. Rullier E, Zerbib F, Marrel A, Amouretti M, Lehur PA. Validation of the French version of the Fecal Incontinence Quality-of-Life (FIQL) scale. Gastroenterol Clin Biol 2004; 28(6-7 Pt 1): 562-8.
16. Leroi AM, Parc Y, Lehur PA et al. ; Study Group. Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg 2005; 242: 662-9.
17. Guillemot F, Leroy J, Boniface M et al. Functional assessment of coloanal anastomosis with reservoir and excision of the anal transition zone. Dis Colon Rectum 1991; 34: 967-72.
18. Demirci S, Gallas S, Bertot-Sassigneux P, Michot F, Denis P, Leroi AM. Anal incontinence: the role of medical management. Gastroenterol Clin Biol 2006; 30: 954-60.
19. Jarrett ME, Matzel KE, Stösser M, Christiansen J, Rosen H, Kamm MA. Sacral nerve stimulation for faecal incontinence following a rectosigmoid resection for colorectal cancer. Int J Colorectal Dis 2005; 20: 446-51.
20. Gallas S, Gourcerol G, Ducrotté P et al. Does magnetic stimulation of sacral nerve roots modify colonic motility ? Results of a randomized double-blind sham-controlled study. Neurogastroenterol Motil 2009; 21: 411-9.
21. Murphy J, Chan CL, Scott SM, Vasudevan SP, Lunniss PJ, Williams NS. Rectal augmentation: short- and mid-term evaluation of a novel procedure for severe fecal urgency with associated incontinence. Ann Surg 2008; 247: 421-7.
22. Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996; 155: 1023-9.
23. Reitz A, Stohrer M, Kramer G et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004; 45: 510-5.
24. Karsenty G, Reitz A, Lindemann G, Boy S, Schurch B. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urology 2006; 68: 1193-7.
25. Ruffion A, Capelle O, Paparel P, Leriche B, Leriche A, Grise P. What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? BJU Int 2006; 97: 1030-4.
26. Jayne DG, Schwandner O, Stuto A. Stapled transanal rectal resection for obstructed defecation syndrome: one-year results of the European STARR Registry. Dis Colon Rectum 2009; 52: 1205-12.
27. Brown CJ, Fenech DS, McLeod RS. Reconstructive techniques after rectal resection for rectal cancer. Cochrane Database Syst Rev 2008; CD006040.
28. Fürst A, Burghofer K, Hutzel L, Jauch KW. Neorectal reservoir is not the functional principle of the colonic J-pouch: the volume of a short colonic J-pouch does not differ from a straight coloanal anastomosis. Dis Colon Rectum 2002; 45: 660-7.
29. Ghalayini IF, Al-Ghazo MA, Elnasser ZA. Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity. Int Urol Nephrol 2009; 41: 805-13.